In the management of patients with type 1 von Willebrand disease, supplementation with Con Facto F® as well as hemodynamic stabilization with appropriate analgesia and sedation may be important to reduce the risk of bleeding.
Keywords: a hemostatic factor; factor VIII concentrate (Confact F®); von Willebrand disease.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.